MEDPLUS HEALTH SERVICES (MEDPLUS): Financials & Fundamentals History

Share price

Closing priceAdjusted for splits and bonus issues.

3M1Y3YAll

₹596 latest close · −27.5% over the last 90 sessions

₹596 month-end · −26.3% over 12 months

₹596 month-end · −25.2% over 3 years

₹596 month-end · −42.5% since Dec '21

52-week range ₹565.60 to ₹1022.20 · 1-year volatility 29.7%

Was the rally earned?

1 year3 years

-26%share price, 1 yearLower P/E held it back

Earnings helped, the multiple did not.

Per-share earnings added 14 points, but investors now pay less per rupee of profit (P/E 54.3x to 34.0x), which took 40 points back.
The share count barely moved.

Net profit growth+15 ptsNet profit rose about 18%, which lifts the price.

P/E change-40 ptsThe P/E fell from 54.3x to 34.0x, which lowers the price.

Share count change0 ptsShare count was little changed. More shares would count against the price.

-25%share price, 3 yearsLower P/E held it back

Earnings helped, the multiple did not.

Per-share earnings added 125 points, but investors now pay less per rupee of profit (P/E 191.2x to 34.0x), which took 150 points back.
The share count barely moved.

Net profit growth+125 ptsNet profit rose about 321%, which lifts the price.

P/E change-150 ptsThe P/E fell from 191.2x to 34.0x, which lowers the price.

Share count change0 ptsShare count was little changed. More shares would count against the price.

What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with NEPHROCARE HEALTH SERV L

How rough has the ride been?

Maximum drawdown-55.3%not yet recovered

1-year volatility29.7%annualised

Beta vs sector index0.333-year daily, correlation 0.22

Volume spikes4last 90 sessions, 5x the 50-day median

Drawdown from peak

Largest drawdowns

-55.3% (2022-01 peak to 2022-11 low, not yet recovered)

Most recent volume spikes

2026-10-15: 5.8x the 50-day median, price -0.1% that day

2026-08-20: 8.4x the 50-day median, price +1.1% that day

2026-07-23: 7.5x the 50-day median, price +3.4% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

34.0xP/E todayNear its historic low

Against its own history13th percentile

CheapestMedian 80.1xDearest

Usual range 30.1x to 180.5x since 2021-12.

Against Retail Trade34.0x vs 22.4x

This company

34.0x

Sector median

22.4x

52% above the Retail Trade median.

P/EP/BP/S

P/E (this company)10th to 90th percentile of its own historyIts medianRetail Trade median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianRetail Trade median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianRetail Trade median

How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Retail Trade is valued

Where does it rank among Retail Trade peers?

Each cell is the company's percentile rank among its Retail Trade peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

ROCE52nd▲ 6 pts vs a year ago
Op. margin43rdflat vs a year ago
Revenue growth42nd▲ 5 pts vs a year ago
EPS growth49th▼ 51 pts vs a year ago
Debt/equity ↓32nd▼ 8 pts vs a year ago
Cash cycle ↓53rd▲ 4 pts vs a year ago
P/E ↓43rdflat vs a year ago
12M momentum34th▼ 56 pts vs a year ago

Rank history

ROCE

Op. margin

Revenue growth

EPS growth

Debt/equity ↓

Cash cycle ↓

P/E ↓

12M momentum

Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26

Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Retail Trade sector page Watch it move against Retail Trade in the Observatory

What is the price implying?

~29%annual earnings growth implied by the price

At a P/E of 61.7x, the price would imply about 29.0%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Fewer than six years of annual earnings are available, which is too little to measure delivered growth.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Retail Trade The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov: ₹596.00
P/E: 34.0x
ROCE: 13.0%
Market Cap: ₹7160 cr
Revenue (TTM): ₹7229 cr
P/S: 1.0x
P/B: 3.6x
ROE: 10.7%
Operating Margin: 7.0%
Debt / Equity: 0.7x
Promoter Holding: 40.2%
12M Momentum: -26.3%

52-week range

₹565.60₹1022.20

7% of the way from its 52-week low to its high

Price risk

1Y volatility

29.7%

Beta vs sector

1-year daily

0.32

Balance sheet & cash

Interest cover

operating profit ÷ interest

3.1x

Cash from profit, 3Y

operating cash flow ÷ net profit

2.71x

Share count, 1Y

unchanged

Are profits backed by cash?

6 of 7checks within range1 near a threshold

Other income reliance29%Near threshold

Other income as a share of pre-tax profit (trailing twelve months): 28.8%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate19%Within range

Median quarterly effective tax rate over about 2.5 years: 19.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion2.71xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 2.71x (cash from operations ₹1,180 cr, net profit ₹436 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow4 of 5 yrsWithin range

Fiscal years with positive free cash flow in the last 5: 4. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history0 daysWithin range

Debtor days are below the median of the previous three fiscal years by 0 days (1 vs 1). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress2% of fixed assetsWithin range

Capital work-in-progress is 2% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+1 days / 2 yrsWithin range

Days payable changed by +1 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

Over 2 years, DIIs added 4.8 pts; FIIs added 1.4 pts.
The number of shareholders rose from 66,048 to 76,005 (+15%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change

Promoters40.5%40.2%-0.3 pts

FIIs13.0%14.4%+1.4 pts

DIIs25.2%29.9%+4.8 pts

Public and others21.3%15.4%-5.9 pts

Number of shareholders

76,005shareholders+15% since Dec '23

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−0.6%typical 12-month return vs the marketNot meaningfully different from the base rate

We found 50 past situations where a non-financial company looked like MEDPLUS HEALTH SERVICES today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
Over the following 12 months the middle half of them returned −14% to +26% vs the market, against −5% for all non-financial companies in the same months.
The gap against the base rate (+4.7%, 80% range −1.3% to +9.3%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge

Similar setups' median

−0.6%

All companies' median

−5.3%

Beat the market

48% vs 44%

50 past situations · 50 companies · 36 months · 2020–2025

The closest matches

Company	When	P/E	ROCE	12M mom.	Drawdown	Next 12 months
SOMANYCERA Producer Manufacturing	Aug 2022	31x	12%	−8%	−32%	+2%
HNDFDS Consumer Non-Durables	Dec 2024	62x	15%	−8%	−24%	−5%
SANSERA Producer Manufacturing	Nov 2023	30x	14%	+7%	−13%	+46%
SUPRAJIT Producer Manufacturing	Dec 2024	46x	12%	+13%	−26%	−4%
TVSSRICHAK Consumer Durables	Jan 2024	44x	9%	+34%	−12%	−35%

Show the other 3 matches

Company	When	P/E	ROCE	12M mom.	Drawdown	Next 12 months
CEATLTD Consumer Durables	May 2021	23x	10%	+63%	−21%	−29%
GODREJIND Process Industries	Dec 2020	26x	10%	−1%	−11%	+10%
PRSMJOHNSN Non-Energy Minerals	Oct 2021	35x	11%	+67%	−18%	−1%

How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, ROCE and P/S. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to MEDPLUS HEALTH SERVICES. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

Feature	Weight	Non-financial	Financial
P/E	1	yes	yes
P/S	1	yes	—
P/B	1	—	yes
ROCE	1	yes	—
operating margin	1	yes	—
ROE	1	—	yes
debt/equity	0.75	yes	—
interest cover	0.5	yes	—
revenue growth	0.75	yes	yes
12-month momentum	1	yes	yes
drawdown from 12-month high	0.75	yes	yes
size	0.75	yes	yes
volatility	0.5	yes	yes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

AFCONS INFRASTRUCTUREAFCONS

Industrial Services

68%similar

debt/equitymarket cap

HERITAGE FOODSHERITGFOOD

Consumer Non-Durables

68%similar

promoter holdingrevenue

JUBILANT PHARMOVAJUBLPHARMA

Health Technology

68%similar

volatilityrevenue

CEATCEATLTD

Consumer Durables

67%similar

debt/equityoperating margin

KALPATARU PROJECTS INTL.KPIL

Industrial Services

65%similar

volatilityrevenue growth

ARVIND FASHIONSARVINDFASN

Retail Trade

64%similar

EPS growthpromoter holding

ADITYA VISIONAVL

Retail Trade

63%similar

market capvolatility

V MART RETAILVMART

Retail Trade

60%similar

ROCErevenue growth

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Mar '23

2026
OctPriceVolume reached 5.8x its 50-day median on 2026-10-15; price -0.1% that day.
SepPeer rankSlipped to the 3rd quartile of Retail Trade on operating margin (from the 2nd quartile).
AugPeer rankMoved into the 2nd quartile of Retail Trade on ROCE (from the 3rd quartile).
JulPriceVolume reached 19.0x its 50-day median on 2026-07-22; price -12.8% that day.
JunPeer rankMoved into the 2nd quartile of Retail Trade on operating margin (from the 3rd quartile).
MayPriceVolume reached 23.3x its 50-day median on 2026-05-21; price +4.7% that day.
MarPeer rankSlipped to the 3rd quartile of Retail Trade on operating margin (from the 2nd quartile).
FebPriceVolume reached 8.5x its 50-day median on 2026-02-09; price +0.2% that day.

Show 22 earlier events

2025
DecPeer rankMoved into the 2nd quartile of Retail Trade on operating margin (from the 3rd quartile).
NovPriceVolume reached 109.4x its 50-day median on 2025-11-03; price +7.5% that day.
SepPeer rankSlipped to the 3rd quartile of Retail Trade on operating margin (from the 2nd quartile).
AugPriceVolume reached 8.4x its 50-day median on 2025-08-05; price -4.6% that day.
JunPeer rankMoved into the 2nd quartile of Retail Trade on operating margin (from the 3rd quartile).
MayPriceVolume reached 8.6x its 50-day median on 2025-05-28; price +1.7% that day.
MarPeer rankSlipped to the 3rd quartile of Retail Trade on operating margin (from the 2nd quartile).
2024
DecInstitutionsFII + DII holding rose 5.7 pts over 1 quarter to 42.7%.
DecPeer rankMoved into the 2nd quartile of Retail Trade on operating margin (from the 3rd quartile).
NovPriceVolume reached 9.3x its 50-day median on 2024-11-19; price +2.7% that day.
SepPeer rankMoved into the top quartile of Retail Trade on EPS growth (from the 2nd quartile).
AugPriceVolume reached 300.3x its 50-day median on 2024-08-26; price +0.4% that day.
JunResultsYear-on-year EPS growth turned positive.
JunPeer rankMoved into the 3rd quartile of Retail Trade on ROCE (from the bottom quartile).
MayPriceVolume reached 5.0x its 50-day median on 2024-05-29; price -1.9% that day.
MarPeer rankSlipped to the bottom quartile of Retail Trade on ROCE (from the 3rd quartile).
FebPriceVolume reached 11.4x its 50-day median on 2024-02-15; price +5.6% that day.
2023
AugPriceVolume reached 161.4x its 50-day median on 2023-08-31; price -8.9% that day.
JunResultsRevenue (TTM) reached a new high of ₹4,558 cr.
JunPeer rankSlipped to the 3rd quartile of Retail Trade on ROCE (from the 2nd quartile).
MayPriceVolume reached 72.6x its 50-day median on 2023-05-26; price +17.9% that day.
MarPriceVolume reached 14.4x its 50-day median on 2023-03-17; price +7.5% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history60 months · 2021-12 to 2026-11

Month	P/E	Revenue (TTM)	ROE	ROCE	Debt / Equity
2026-11	34.0x	₹7229 cr	10.7%	13.0%	0.7x
2026-10	33.1x	₹7229 cr	10.7%	13.0%	0.7x
2026-09	37.3x	₹7229 cr	10.7%	13.0%	0.7x
2026-08	36.7x	₹6892 cr	11.1%	13.0%	0.7x
2026-07	38.5x	₹6892 cr	11.1%	13.0%	0.7x
2026-06	44.3x	₹6892 cr	11.1%	13.0%	0.7x
2026-05	51.8x	₹6538 cr	11.9%	10.0%	0.6x
2026-04	50.5x	₹6538 cr	11.9%	10.0%	0.6x
2026-03	48.6x	₹6538 cr	11.9%	10.0%	0.6x
2026-02	52.0x	₹6293 cr	11.2%	10.0%	0.6x
2026-01	49.0x	₹6293 cr	11.2%	10.0%	0.6x
2025-12	49.6x	₹6293 cr	11.2%	10.0%	0.6x
2025-11	54.3x	₹6190 cr	10.2%	10.0%	0.6x
2025-10	51.2x	₹6190 cr	10.2%	10.0%	0.6x
2025-09	50.8x	₹6190 cr	10.2%	10.0%	0.6x
2025-08	67.0x	₹6136 cr	8.6%	10.0%	0.6x
2025-07	74.1x	₹6136 cr	8.6%	10.0%	0.6x
2025-06	72.0x	₹6136 cr	8.6%	10.0%	0.6x
2025-05	87.4x	₹6116 cr	8.4%	7.0%	0.6x
2025-04	72.9x	₹6116 cr	8.4%	7.0%	0.6x
2025-03	68.7x	₹6116 cr	8.4%	7.0%	0.6x
2025-02	85.3x	₹5996 cr	6.4%	7.0%	0.6x
2025-01	86.3x	₹5996 cr	6.4%	7.0%	0.6x
2024-12	99.1x	₹5996 cr	6.4%	7.0%	0.6x
2024-11	123.1x	₹5829 cr	4.9%	7.0%	0.6x
2024-10	104.9x	₹5829 cr	4.9%	7.0%	0.6x
2024-09	105.5x	₹5829 cr	4.9%	7.0%	0.6x
2024-08	124.0x	₹5625 cr	4.2%	7.0%	0.6x
2024-07	124.1x	₹5625 cr	4.2%	7.0%	0.6x
2024-06	124.5x	₹5625 cr	4.2%	7.0%	0.6x
2024-05	175.4x	₹4558 cr	3.4%	5.0%	0.6x
2024-04	167.1x	₹4558 cr	3.4%	5.0%	0.6x
2024-03	165.0x	₹4558 cr	3.4%	5.0%	0.6x
2024-02	166.9x	₹4558 cr	3.4%	5.0%	0.6x
2024-01	171.8x	₹4558 cr	3.4%	5.0%	0.6x
2023-12	180.0x	₹4558 cr	3.4%	5.0%	0.6x
2023-11	191.2x	₹4558 cr	3.4%	5.0%	0.6x
2023-10	189.8x	₹4558 cr	3.4%	5.0%	0.6x
2023-09	184.4x	₹4558 cr	3.4%	5.0%	0.6x
2023-08	194.6x	₹4558 cr	3.4%	5.0%	0.6x
2023-07	230.0x	₹4558 cr	3.4%	5.0%	0.6x
2023-06	185.8x	₹4558 cr	3.4%	5.0%	0.6x
2023-05	101.1x	₹3779 cr	6.7%	10.0%	0.6x
2023-04	92.1x	₹3779 cr	6.7%	10.0%	0.6x
2023-03	80.9x	₹3779 cr	6.7%	10.0%	0.6x
2023-02	82.9x	₹3779 cr	6.7%	10.0%	0.6x
2023-01	79.2x	₹3779 cr	6.7%	10.0%	0.6x
2022-12	76.4x	₹3779 cr	6.7%	10.0%	0.6x
2022-11	85.3x	₹3779 cr	6.7%	10.0%	0.6x
2022-10	73.8x	₹3779 cr	6.7%	10.0%	0.6x
2022-09	77.0x	₹3779 cr	6.7%	10.0%	0.6x
2022-08	91.5x	₹3779 cr	6.7%	10.0%	0.6x
2022-07	92.4x	₹3779 cr	6.7%	10.0%	0.6x
2022-06	95.6x	₹3779 cr	6.7%	10.0%	0.6x
2022-05	3.1x	₹3069 cr	8.6%	13.0%	0.8x
2022-04	3.6x	₹3069 cr	8.6%	13.0%	0.8x
2022-03	3.7x	₹3069 cr	8.6%	13.0%	0.8x
2022-02	3.7x	₹3069 cr	8.6%	13.0%	0.8x
2022-01	3.9x	₹3069 cr	8.6%	13.0%	0.8x
2021-12	3.7x	₹3069 cr	8.6%	13.0%	0.8x

Methodology and data notes